coming News newsbot.ch

Wirtschaft »

Roche’s satralizumab significantly reduced relapse risk in second  positive phase III study for neuromyelitis optica spectrum

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

2019-09-12 13:20:00


Regional »

Unity Event des Jugendparlaments

Unity Event des Jugendparlaments

2019-08-30 08:36:03


Wirtschaft »

Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer

2019-08-05 05:40:23


Wirtschaft »

FDA grants Roche’s Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer

2019-03-11 08:40:04


Wirtschaft »

Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions

2019-03-07 14:20:29



Suchresultate als RSS-Feed